Compare · DFTX vs PAVS
DFTX vs PAVS
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and Paranovus Entertainment Technology Ltd. (PAVS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and PAVS operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $2.51B, about 4858.6x PAVS ($516,761).
- Over the past year, DFTX is up 181.1% and PAVS is down 99.3% - DFTX leads by 280.5 points.
- DFTX has been more active in the news (3 items in the past 4 weeks vs 1 for PAVS).
- DFTX has more recent analyst coverage (4 ratings vs 0 for PAVS).
PerformanceDFTX+181.13%PAVS-99.32%
2025-06-09+0.00%2026-06-09
- Company
- Definium Therapeutics Inc.
- Paranovus Entertainment Technology Ltd.
- Price
- $21.83-5.17%
- $8.00+737.70%
- Market cap
- $2.51B
- $516,761
- 1M return
- -1.09%
- +525.00%
- 1Y return
- +181.13%
- -99.32%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2019
- News (4w)
- 3
- 1
- Recent ratings
- 4
- 0
Latest DFTX
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
- Definium Therapeutics Announces New Employee Inducement Grants
- SEC Form 10-Q filed by Definium Therapeutics Inc.
- Definium Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
- Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026
Latest PAVS
- SEC Form 424B5 filed by Paranovus Entertainment Technology Ltd.
- SEC Form 6-K filed by Paranovus Entertainment Technology Ltd.
- SEC Form 6-K filed by Paranovus Entertainment Technology Ltd.
- SEC Form 6-K filed by Paranovus Entertainment Technology Ltd.
- SEC Form 3 filed by new insider Xu Minzhu
- SEC Form 6-K filed by Paranovus Entertainment Technology Ltd.
- Paranovus Entertainment Technology Limited Announces 1-For-12 Reverse Share Split
- SEC Form 6-K filed by Paranovus Entertainment Technology Ltd.
- SEC Form 424B5 filed by Paranovus Entertainment Technology Ltd.
- Paranovus Entertainment Technology Limited Announces Pricing of $5 Million Registered Direct Offering At-The-Market Under NASDAQ Rules